Published online Nov 16, 2014. doi: 10.12998/wjcc.v2.i11.705
Revised: September 23, 2014
Accepted: October 14, 2014
Published online: November 16, 2014
AIM: To evaluate the effect of chemotherapy to the acute toxicity of a hypofractionated radiotherapy (HFRT) schedule for breast cancer.
METHODS: We retrospectively analyzed 116 breast cancer patients with T1, 2N0Mx. The patients received 3-D conformal radiotherapy with a total physical dose of 50.54 Gy or 53.2 Gy in 19 or 20 fractions according to stage, over 23-24 d. The last three to four fractions were delivered as a sequential tumor boost. All patients were monitored for acute skin toxicity according to the European Organization for Research and Treatment of Cancer/Radiation Therapy Oncology Group criteria. The maximum monitored value was taken as the final grading score. Multivariate analysis was performed for the contribution of age, chemotherapy and 19 vs 20 fractions to the radiation acute skin toxicity.
RESULTS: The acute radiation induced skin toxicity was as following: grade I 27.6%, grade II 7.8% and grade III 2.6%. No significant correlation was noted between toxicity grading and chemotherapy (P = 0.154, χ2 test). The mean values of acute toxicity score in terms of chemotherapy or not, were 0.64 and 0.46 respectively (P = 0.109, Mann Whitney test). No significant correlation was also noted between acute skin toxicity and radiotherapy fractions (P = 0.47, χ2 test). According to univariate analysis, only chemotherapy contributed significantly to the development of acute skin toxicity but with a critical value of P = 0.05. However, in multivariate analysis, chemotherapy lost its statistical significance. None of the patients during the 2-years of follow-up presented any locoregional relapse.
CONCLUSION: There is no clear evidence that chemotherapy has an impact to acute skin toxicity after an HFRT schedule. A randomized trial is needed for definite conclusions.
Core tip: The adjuvant radiotherapy for early breast cancer after lumpectomy is an established treatment. Hypofractionation is an attractive approach and the trend nowadays towards new techniques involving hypofractionation is huge, mainly due to the long waiting lists, patients’ desire for fast treatment, better planning of radiotherapy with computed tomography-based target definition and better dose homogeneity assured by 3D conformal planning. The aim of the current study is to evaluate the potential effect of previous chemotherapy to the acute skin toxicity and the local control followed for 2 years in patients with breast cancer, treated with hypofractionated radiotherapy regimen.